Characterizing plasma lipid species in metabolic dysfunction associated steatotic liver disease in persons with type 1 diabetes

Characterizing plasma lipid species in metabolic dysfunction associated steatotic liver disease in persons with type 1 diabetes

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is the hepatic manifestation of metabolic syndrome. Hepatic lipotoxicity and inflammation are two key factors driving progression of steatosis to metabolic dysfunction-associated steatohepatitis (MASH). The presence of MASH in...

Full description

Saved in:
Bibliographic Details
Main Authors: Adeyinka Taiwo, Himani Thakkar, J. Alan Maschek, James Cox, Scott A. Summers, Diana Jalal, Ayotunde Dokun, William I. Sivitz, Bhagirath Chaurasia
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Fatty liver
Steatosis
Diabetes mellitus
Type 1
Cross-sectional study
Insulin resistance
Online Access:https://doi.org/10.1038/s41598-025-15778-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-15778-z

Similar Items